The impact of the EUSCLE core set questionnaire for the assessment of cutaneous lupus erythematosus

Lupus

Volumn 19, Issue 9, 2010, Pages 1144-1152

  Kuhn, A ^a   Patsinakidis, N ^a   Bonsmann, G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

ACR criteria; antinuclear antibodies; autoimmune disease; cutaneous lupus erythematosus; diagnosis; epidemiology; Europe; photosensitivity; questionnaire

Indexed keywords

ANTIMALARIAL AGENT; CALCINEURIN INHIBITOR; DAPSONE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RETINOID DERIVATIVE; STEROID; THALIDOMIDE;

CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE ASSOCIATION; EUROPEAN SOCIETY OF CUTANEOUS LUPUS ERYTHEMATOSUS CORE SET QUESTIONNAIRE; EVALUATION; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; PHOTOSENSITIVITY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SKIN LUPUS ERYTHEMATOSUS; SMOKING; STANDARDIZATION;

CLINICAL TRIALS AS TOPIC; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 77955537218     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310370346     Document Type: Review

References (78)

1. Jimenez S., Cervera R., Ingelmo M., Font J. The epidemiology of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Berlin: Springer-Verlag; 2004. p. 45-52.
2. Tebbe B., Orfanos CE Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997 ; 6: 96-104.
3. Popovic K., Nyberg F., Wahren-Herlenius M. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Arthritis Rheum 2007 ; 56: 255-264.
4. Gilliam JN The cutaneous signs of lupus erythematosus. Cont Educ Fam Phys 1977 ; 6: 34-70.
5. Gilliam JN, Sontheimer RD Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 1981 ; 4: 471-475.
6. Gilliam JN, Sontheimer RD Skin manifestations of SLE. Clin Rheum Dis 1982 ; 8: 207-218.
7. Kuhn A., Ruzicka T. Classification of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Heidelberg: Springer; 2004. p. 53-58.
8. Costner MI, Sontheimer RD, Provost TT Lupus erythematosus. In: Sontheimer RD, Provost TT (eds), Cutaneous Manifestations of Rheumatic Diseases. Philadelphia, PA: Williams & Wilkins; 2003. p. 15-64.
9. Sontheimer RD Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 2005 ; 4: 253-263.
10. Tebbe B., Mansmann U., Wollina U., et al. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol 1997 ; 77: 305-308.
11. Kuhn A., Lehmann P., Ruzicka T. Clinical manifestations of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Heidelberg: Springer; 2004. p. 59-92.
12. Kuhn A., Richter-Hintz D., Oslislo C., Ruzicka T., Megahed M., Lehmann P. Lupus erythematosus tumidus - a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 2000 ; 136: 1033-1041.
13. Kuhn A., Bein D., Bonsmann G. The 100th anniversary of lupus erythematosus tumidus. Autoimmun Rev 2009 ; 8: 441-448.
14. Kuhn A., Kuehn E., Meuth AM, et al. Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev 2009 ; 8: 702-712.
15. Albrecht J., Taylor L., Berlin JA, et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 2005 ; 125: 889-894.
16. Albrecht J., Werth VP Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus. Dermatol Ther 2007 ; 20: 93-101.
17. Vieira V., Del Pozo J., Yebra-Pimentel MT, Martinez W., Fonseca E. Lupus erythematosus tumidus: a series of 26 cases. Int J Dermatol 2006 ; 45: 512-517.
18. Alexiades-Armenakas MR, Baldassano M., Bince B., et al. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum 2003 ; 49: 494-500.
19. Albrecht J., Berlin JA, Braverman IM, et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus 2004 ; 13: 839-849.
20. Uetrecht J. Drug-induced lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Berlin: Springer ; 2005. p. 117-132.
21. Bonsmann G., Schiller M., Luger TA, Stander S. Terbinafineinduced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001 ; 44: 925-931.
22. Srivastava M., Rencic A., Diglio G., et al. Drug-induced, Ro/ SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003 ; 139: 45-49.
23. Sontheimer RD The lexicon of cutaneous lupus erythematosus-a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 1997 ; 6: 84-95.
24. Kuhn A., Beissert S. Photosensitivity in lupus erythematosus. Autoimmunity 2005 ; 38: 519-529.
25. Nyberg F., Hasan T., Puska P., et al. Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 1997 ; 136: 217-221.
26. Millard TP, Hawk JL, McGregor JM Photosensitivity in lupus. Lupus 2000 ; 9: 3-10.
27. Callen JP Management of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Berlin: Springer; 2004. p. 437-444.
28. Kuhn A., Sonntag M., Richter-Hintz D., et al. Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 2001 ; 45: 86-95. (Pubitemid 32655700)
29. Ramos-Casals M., Brito-Zeron P., Font J. The overlap of Sjogrens syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum 2007 ; 36: 246-255.
30. Manoussakis MN, Georgopoulou C., Zintzaras E., et al. Sjogrens syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogrens syndrome. Arthritis Rheum 2004 ; 50: 882-891.
31. Kuhn A., Richter-Hintz D., Schuppe HC, Ruzicka T., Lehmann P. Annular erythema in Sjogren syndrome. A variant of cutaneous lupus erythematosus? Hautarzt 2000 ; 51: 270-275.
32. Bernatsky S., Boivin JF, Joseph L., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006 ; 54: 2550-2557.
33. McDonagh JE, Isenberg DA Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 2000 ; 59: 230-232.
34. Daldon PE, Macedo de Souza E., Cintra ML Hypertrophic lupus erythematosus: a clinicopathological study of 14 cases. J Cutan Pathol 2003 ; 30: 443-438.
35. Chaudhry SI, Murphy LA, White IR Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis? Clin Exp Dermatol 2005 ; 30: 655-658.
36. Provost TT Nonspecific cutaneous manifestations of systemic lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Heidelberg: Springer; 2004. p. 93-106.
37. Meurer M. Immunopathology of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Heidelberg: Springer; 2004. p. 305-310.
38. Halberg P., Ullman S., Jorgensen F. The lupus band test as a measure of disease activity in systemic lupus erythematosus. Arch Dermatol 1982 ; 118: 572-576.
39. Prystowsky SD, Herndon JH, Gilliam JN Chronic cutaneous lupus erythematosus (DLE): a clinical and laboratory investigation of 80 patients. Medicine 1976 ; 55: 183.
40. Sontheimer RD, Thomas JR, Gilliam JN Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979 ; 115: 1409-1415.
41. Fabre VC, Lear S., Reichlin M., Hodge SJ, Callen JP Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence. Arch Dermatol 1991 ; 127: 1006-1011.
42. Dahl MV, Gilliam JN Direct Immunofluorescence in lupus erythematosus. In: Beutner EH, Chorzelski TP, Kumar V (eds), Immunopathology of the Skin. New York: John Wiley and Sons; 1987. p. 499-518.
43. Lehmann P., Kuhn A. Photosensitivity in lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Heidelberg: Springer; 2004. p. 161-175.
44. Shinada S., Wallace DJ Laboratory features of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Berlin: Springer-Verlag; 2004. p. 311-321.
45. Wiik AS Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005 ; 34: 260-268.
46. Hartung K., Seelig HP [Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses.]. Z Rheumatol 2006 ; 65: 709-724.
47. Kurien BT, Scofield RH Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 2006 ; 64: 227-235.
48. Beutner EH, Blaszczyk M., Jablonska S., Chorzelski TP, Vijay K., Wolska H. Studies on criteria of the European Academy of Dermatology and Venereology for the classification of cutaneous lupus erythematosus. Int J Dermatol 1991 ; 30: 411-417.
49. Chlebus E., Wolska H., Blaszczyk M., Jablonska S. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol 1998 ; 38: 405-412.
50. Callen JP, Klein J. Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients. Arthritis Rheum 1988 ; 31: 1007-1013.
51. Sanchez NP, Peters MS, Winkelmann RK The histopathology of lupus erythematosus panniculitis. J Am Acad Dermatol 1981 ; 122: 576-582.
52. Wenzel J., Bauer R., Bieber T., Bohm I. Autoantibodies in patients with Lupus erythematosus: spectrum and frequencies. Dermatology 2000 ; 201: 282-283.
53. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in healthy individuals. Arthritis Rheum 1997 ; 40: 1601-1611.
54. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000 ; 53: 424-432.
55. Sontheimer RD, Maddison PJ, Reichlin M., Jordon RE, Stastny P., Gilliam JN Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 1982 ; 97: 664-671.
56. Wallace DJ, Pistiner M., Nessim S., Metzger AL, Klinenberg JR Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features. Semin Arthritis Rheum 1992 ; 21: 221-226.
57. Boeckler P., Milea M., Meyer A., et al. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency. Br J Dermatol 2005 ; 152: 265-270.
58. Vogt B., Fuhrnrohr B., Muller R., Sheriff A. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity 2007 ; 40: 295-298.
59. Williams Jr RC, Harmon ME, Burlingame R., Du Clos TW Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol 2005 ; 32: 454-461.
60. Chen JL, Huang XM, Zeng XJ, et al. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases]. Zhonghua Yi Xue Za Zhi 2007 ; 87: 1330-1333.
61. Specker C., Schneider M. Relationship between cutaneous and systemic lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds), Cutaneous Lupus Erythematosus. Heidelberg: Springer ; 2004. p. 177-186.
62. Jessop S., Whitelaw D., Jordaan F. Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev 2001 ; 1: CD002954.
63. Jewell ML, McCauliffe DP Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 2000 ; 42: 983-987.
64. Rahman P., Gladman DD, Urowitz MB Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 1998 ; 25: 1716-1719.
65. Polet H. The effects of lysosomotropic amines on protein degradation, migration of nonhistone proteins to the nucleus, and cathepsin D in lymphocytes. J Cell Physiol 1985 ; 122: 415-423.
66. Miot HA, Bartoli, Miot LD, Haddad GR Association between discoid lupus erythematosus and cigarette smoking. Dermatology 2005 ; 211: 118-122.
67. Costenbader KH, Kim DJ, Peerzada J. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004 ; 50: 84s9-857.
68. Mok CC, Wong RW Pregnancy in systemic lupus erythematosus. Postgrad Med J 2001 ; 77: 157-165.
69. Wong KL, Chan FY, Lee CP Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 1991 ; 151: 269-273.
70. Petri M., Howard D., Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991 ; 34: 1538-1545.
71. Ruiz-Irastorza G., Lima F., Alves J., et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996 ; 35: 133-138.
72. Lockshin MD, Reinitz E., Druzin ML, Murrman M., Estes D. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984 ; 77: 893-898.
73. Mintz G., Niz J., Gutierrez G., Garcia-Alonso A., Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986 ; 13: 732-739.
74. Lockshin MD Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989 ; 32: 665-670.
75. Urowitz MB, Gladman DD, Farewell VT, Stewart J., McDonald J. Lupus and pregnancy studies. Arthritis Rheum 1993 ; 36: 1392-1397.
76. Fischer-Betz R., Tutschek B. Systemische immunologische Erkrankungen in der Schwangerschaft. CME Praktische Fortbildung GynCurrency signkologie, Geburtsmedizin und GynCurrency signkologische Endokrinologie 2006 ; 2: 48-59.
77. Yan Yuen S., Krizova A., Ouimet JM, Pope JE Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) is Improving: Results from a Case Control Study and Literature Review. Open Rheumatol J 2008 ; 2: 89-98.
78. Yell JA, Burge SM The effect of hormonal changes on cutaneous disease in lupus erythematosus. Br J Dermatol 1993 ; 129: 18-22.